Does Isotretinoin (Accutane) Cause Inflammatory Bowel Disease? What the Research Shows

Does isotretinoin (Accutane) cause inflammatory bowel disease? The best current evidence says no clear link exists. Early case reports and one 2010 study raised concern about ulcerative colitis, but a 2023 meta-analysis of eight studies with 2.5 million people found no increased odds of inflammatory bowel disease with isotretinoin. A 2023 cohort study found acne itself, not its treatments, was linked to IBD. Isotretinoin does carry serious, well-documented risks, especially severe birth defects.

Isotretinoin, sold originally as Accutane and now under several generic names, is the most effective treatment for severe acne, often clearing it permanently after a single course. For years, it was also the subject of thousands of lawsuits by people who developed Crohn’s disease or ulcerative colitis after taking it, some of whom described life-changing bowel damage and surgeries. Juries awarded large verdicts, and the original manufacturer withdrew the brand from the U.S. market in 2009. Since then, larger and better-designed studies have reexamined the question. This article explains what research shows about isotretinoin and IBD, why early findings differed, the drug’s established risks, and how patients can make informed decisions.

Why Did Isotretinoin Become Linked to Bowel Disease?

Reports of people developing inflammatory bowel disease during or after isotretinoin treatment appeared in medical literature and the FDA’s adverse event database, and the drug’s label included warnings about IBD. Because isotretinoin is often taken by teenagers and young adults, the same age group in which Crohn’s disease and ulcerative colitis commonly first appear, some cases would be expected by chance. Lawsuits in the 2000s argued that the manufacturer had not adequately warned about the risk, and several juries agreed, awarding millions of dollars. Roche, the maker of Accutane, discontinued the brand in the United States in 2009, citing competition from generics and litigation costs, while generic versions remained available.

What Did the 2010 Study Find?

A 2010 case-control study in The American Journal of Gastroenterology by Seth Crockett and colleagues used a large insurance claims database to compare people newly diagnosed with IBD with matched controls. Previous isotretinoin use was associated with about 4.4 times the odds of ulcerative colitis, with higher odds at larger doses and with more than two months of use, but there was no association with Crohn’s disease. The authors cautioned that the absolute risk was likely small and that clinicians and patients should be aware of a possible association. This study was among the most influential pieces of evidence cited in the IBD debate.

What Did Larger Studies Find?

A 2013 study in JAMA Dermatology by Mahyar Etminan and colleagues identified 2,159 IBD cases among women aged 18 to 46 in a U.S. health claims database and matched them with 43,180 controls. Isotretinoin exposure was almost identical in the two groups, 0.46 versus 0.44 percent, with an adjusted relative risk of 0.99. A meta-analysis of five studies in the same paper found a pooled relative risk of 0.94. A 2023 systematic review in the American Journal of Clinical Dermatology by Yu and colleagues pooled eight case-control and cohort studies with 2,522,422 participants and found no increased odds of IBD (odds ratio 1.01), Crohn’s disease (0.87), or ulcerative colitis (1.27, not statistically significant). Trial sequential analysis suggested further studies were unlikely to change the conclusion, and the authors stated that isotretinoin should not be withheld because of IBD concerns.

Could Acne Itself Explain the Link?

Recent evidence suggests it might. A 2023 propensity-matched cohort study in the Journal of the American Academy of Dermatology by Taylor and colleagues, including dermatologist John Barbieri, compared the one-year incidence of IBD among people without acne and among people with acne treated with no systemic medicine, with tetracycline-class antibiotics, or with isotretinoin. Acne itself was associated with 42 percent higher odds of new IBD compared with no acne, while neither oral antibiotics nor isotretinoin showed a significant association. This pattern suggests that shared inflammation or other factors connecting acne and IBD, rather than the treatment, may explain some earlier findings. People with severe acne also often take antibiotics before isotretinoin, and some studies have examined whether antibiotics, which alter gut bacteria, play a role.

How Did the Lawsuits End?

Thousands of IBD lawsuits were consolidated in New Jersey state court. Although plaintiffs won several early verdicts, some awards were overturned on appeal. In 2018, the New Jersey Supreme Court upheld a decision to exclude the plaintiffs’ expert testimony on whether isotretinoin causes Crohn’s disease, finding that the experts had not reliably applied the scientific evidence, a ruling that effectively ended most of the remaining cases. The legal outcome mirrors the scientific shift: as larger studies accumulated, the evidence for a causal link weakened. Patients who experienced bowel disease after isotretinoin suffered real harm, but research has not shown that the drug caused it.

What Are Isotretinoin’s Established Risks?

The most serious is birth defects. Isotretinoin taken during pregnancy can cause severe malformations of the brain, heart, face, and other organs, as well as miscarriage. In the United States, the iPLEDGE program requires patients who can become pregnant to use two forms of contraception, have monthly pregnancy tests, and register with prescribers and pharmacies. A 2019 analysis in JAMA Dermatology by Elizabeth Tkachenko and colleagues reviewed FDA adverse event reports from 1997 to 2017 and found that reported pregnancies, abortions, and fetal defects among women taking isotretinoin fell after iPLEDGE began in 2006 but continued to occur, with an estimated pregnancy rate between 0.33 and 0.65 percent among females of childbearing potential. Other common effects include very dry skin and lips, dry eyes, nosebleeds, muscle and joint aches, sensitivity to sunlight, and rises in blood triglycerides and liver enzymes, which are monitored with blood tests.

Does Isotretinoin Cause Depression?

This concern has also been studied extensively. Isotretinoin labels warn about depression, psychosis, and suicidal thoughts, and doctors screen for mood changes during treatment. A 2019 meta-analysis in BMJ Open by Li and colleagues analyzed 20 studies. In 17 studies, depressive symptoms improved on average from before to after treatment, and in four studies comparing isotretinoin with other acne treatments, there was no increased risk of depression. Severe acne itself is linked to depression and anxiety, and clearing it can improve mood. Still, individual reactions can occur, so patients and families should report new sadness, irritability, withdrawal, or thoughts of self-harm promptly, and anyone in crisis should seek immediate help.

How Effective Is Isotretinoin for Acne?

It is the most powerful acne treatment available, but trial data are less complete than many assume. A 2018 Cochrane review by Costa and colleagues found that isotretinoin is the only acne drug that targets all main causes of acne, but rated much of the trial evidence as low quality because of small studies, varying regimens, and incomplete reporting. Clinical experience and observational data show that many people with severe, scarring, or treatment-resistant acne achieve long-lasting remission after a single course. Guidelines reserve it mainly for severe or scarring acne and for moderate acne that has not responded to other treatments, given its side effects and monitoring requirements.

How Do Isotretinoin’s Risks Compare?

How Does Isotretinoin Work?

Isotretinoin is a form of vitamin A that shrinks the oil glands in the skin and greatly reduces sebum production, one of the main drivers of acne. It also normalizes how skin cells line hair follicles, reducing clogged pores, and lowers inflammation and the bacteria that thrive in oily follicles. Because it addresses all of these causes at once, a course typically lasting four to six months can produce long-term improvement even after the drug is stopped. Its effects on oil glands and other tissues that depend on vitamin A signaling also explain many of its side effects, including dryness and its danger to a developing fetus.

What Monitoring Happens During Treatment?

Before starting, patients usually have baseline blood tests for liver function and blood fats, and those who can become pregnant need negative pregnancy tests and must commit to contraception under iPLEDGE. During treatment, monthly visits check acne progress, side effects, mood, and, for those who can become pregnant, repeat pregnancy tests. Blood tests may be repeated, especially if doses increase. Patients are advised not to donate blood during treatment and for a month afterward, to avoid vitamin A supplements, to limit alcohol, and to protect their skin from the sun. Because isotretinoin can interact with tetracycline antibiotics and raise the risk of increased pressure around the brain, these are not taken together.

Do Antibiotics Used for Acne Affect Gut Health?

Long courses of oral antibiotics for acne have raised separate questions, since antibiotics change gut bacteria, which play a role in IBD. Some earlier studies suggested a possible link between tetracycline-class antibiotics and IBD, but the 2023 cohort study by Taylor and colleagues found no significant association. Dermatology guidelines now recommend limiting oral antibiotic courses for acne, combining them with topical benzoyl peroxide to reduce resistance, and stopping them when acne improves, partly for these reasons. Our article on fluoroquinolone antibiotics discusses other antibiotic safety concerns.

What Bowel Symptoms Should Prompt a Doctor Visit?

Regardless of what causes it, inflammatory bowel disease needs prompt evaluation. Warning signs include diarrhea lasting more than a couple of weeks, blood or mucus in the stool, persistent abdominal pain or cramping, urgent need to use the bathroom, unexplained weight loss, fatigue, and fever. Anyone taking isotretinoin who develops these symptoms should contact their prescriber, who may pause treatment and arrange testing. Early diagnosis and treatment of Crohn’s disease and ulcerative colitis reduce complications, including the need for surgery.

Should People With IBD or a Family History Avoid Isotretinoin?

Not necessarily, but they should discuss it carefully. Because large studies have not found that isotretinoin causes IBD, many dermatologists will consider it for people with a family history of IBD or even existing, well-controlled IBD, working with the patient’s gastroenterologist. Decisions weigh the severity of acne, scarring risk, the effect of acne on quality of life, and other treatment options. Patients should share their full medical history, including bowel symptoms and medications, before starting treatment.

What Are the Alternatives to Isotretinoin?

For mild to moderate acne, topical treatments such as benzoyl peroxide, topical retinoids like adapalene or tretinoin, azelaic acid, and topical antibiotics combined with benzoyl peroxide are first-line options. Oral antibiotics such as doxycycline are used for moderate inflammatory acne, ideally for limited periods to reduce antibiotic resistance. For women, hormonal treatments such as combined oral contraceptives or spironolactone can be effective. Some dermatologists use lower doses of isotretinoin to reduce side effects. Procedures such as chemical peels and light-based therapies may help some people. The best choice depends on acne type, severity, scarring, and personal health factors.

Why Do Some Patients Still Believe Isotretinoin Harmed Them?

Because their experiences are real. People who developed severe bowel disease after taking isotretinoin endured painful symptoms, surgeries, and lasting effects, and the timing understandably suggested a connection. Population studies can show whether a drug raises risk across large groups, but they cannot tell any one person what caused their disease. Acknowledging patients’ suffering while explaining what the best evidence shows, and continuing to monitor for rare effects, is part of responsible medicine. Reporting suspected side effects to the FDA’s MedWatch program helps keep safety monitoring active.

How Common Is Inflammatory Bowel Disease in Young People?

IBD most often begins between the ages of 15 and 35, overlapping almost exactly with the years when people take isotretinoin for acne. In the United States, an estimated 2.4 to 3.1 million people live with IBD, and new diagnoses in children and young adults have risen in many countries over recent decades. Because so many teenagers and young adults take isotretinoin, and because IBD begins in the same age range, some people would develop IBD during or after treatment purely by coincidence. This overlap is a key reason careful comparison studies, rather than individual case reports, are needed to judge whether a drug raises risk.

What Questions Should Patients Ask Before Starting Isotretinoin?

Useful questions include: How severe is my acne, and what other treatments have I tried? What results can I expect, and how long will the course last? What side effects are most likely for me, and how will we monitor them? What contraception and testing does iPLEDGE require in my situation? How will we watch for mood changes, and who should I contact if I feel worse? Should I avoid any medicines, supplements, or activities during treatment? Does my personal or family history, including bowel conditions, change the plan? Writing answers down and involving a parent or partner can help, especially for teenagers.

Common Myths

“Isotretinoin definitely causes Crohn’s disease or colitis.” Large studies and a 2023 meta-analysis found no association.

“Because Accutane was withdrawn, it was banned.” The brand was discontinued in 2009; generic isotretinoin remains FDA-approved.

“Isotretinoin always causes depression.” On average, depressive symptoms improved during treatment, though individual reactions can occur.

“Birth defect warnings are exaggerated.” The risk is severe and well established, which is why iPLEDGE exists.

“One course of isotretinoin fails for most people.” Many people with severe acne achieve lasting remission after one course.

Key Terms

Isotretinoin: An oral vitamin A derivative used for severe acne, originally sold as Accutane.

Inflammatory bowel disease (IBD): Chronic intestinal inflammation, mainly Crohn’s disease and ulcerative colitis.

iPLEDGE: The U.S. program that manages isotretinoin prescribing to prevent pregnancy exposure.

Case-control study: A study comparing past exposures in people with and without a disease.

Propensity score matching: A method for comparing similar groups of patients in observational data.

The Bottom Line

Concern that isotretinoin causes inflammatory bowel disease grew from case reports, a 2010 study linking it to ulcerative colitis, and thousands of lawsuits. Larger studies since then, including a 2013 analysis with more than 43,000 controls and a 2023 meta-analysis of 2.5 million people, found no increased risk, and a 2023 cohort study linked IBD to acne itself rather than to its treatments. Isotretinoin remains highly effective for severe acne but carries well-established risks, especially severe birth defects, along with common side effects that require monitoring. Patients should discuss benefits and risks with a dermatologist and report any persistent bowel or mood changes.

Frequently Asked Questions

Does Accutane cause inflammatory bowel disease?

Current evidence does not show that it does. A 2023 meta-analysis of eight studies with more than 2.5 million people found no increased odds of IBD, Crohn’s disease, or ulcerative colitis with isotretinoin. An earlier 2010 study linked it to ulcerative colitis, but later, larger studies did not confirm that finding.

Why was Accutane taken off the market?

Roche discontinued the Accutane brand in the United States in 2009, citing competition from generic versions and the costs of lawsuits. It was not banned by the FDA. Generic isotretinoin, sold under several names, remains approved and widely prescribed for severe acne under the iPLEDGE safety program.

Is acne linked to bowel disease?

A 2023 matched cohort study found people with acne had about 42 percent higher odds of developing IBD within a year compared with people without acne, while isotretinoin and tetracycline antibiotics were not associated with IBD. Shared inflammatory pathways may explain the link, though more research is needed.

What are the most serious risks of isotretinoin?

The most serious is severe birth defects if taken during pregnancy, which is why the iPLEDGE program requires contraception and pregnancy testing. Other risks include very dry skin and eyes, nosebleeds, raised blood fats and liver enzymes, and, in some people, mood changes. Regular monitoring by a prescriber helps manage these risks.

Can isotretinoin cause depression?

Labels warn about depression and suicidal thoughts, and doctors screen for mood changes. However, a 2019 meta-analysis of 20 studies found depressive symptoms improved on average during treatment, and comparison studies found no increased risk. Anyone noticing mood changes should contact their prescriber promptly.

References

1. Crockett SD, Porter CQ, Martin CF, et al. Isotretinoin use and the risk of inflammatory bowel disease: a case-control study. American Journal of Gastroenterology. 2010;105(9):1986–1993. PMID 20354506
2. Etminan M, Bird ST, Delaney JA, et al. Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. JAMA Dermatology. 2013;149(2):216–220. PMID 23426479
3. Yu CL, Chou PY, Liang CS, et al. Isotretinoin exposure and risk of inflammatory bowel disease: a systematic review with meta-analysis and trial sequential analysis. American Journal of Clinical Dermatology. 2023;24(5):721–730. PMID 37010780
4. Taylor MT, Margolis DJ, Kwatra SG, et al. A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin exposure, with inflammatory bowel disease. Journal of the American Academy of Dermatology. 2023;88(4):841–847. PMID 36682724
5. Tkachenko E, Singer S, Sharma P, et al. US Food and Drug Administration reports of pregnancy and pregnancy-related adverse events associated with isotretinoin. JAMA Dermatology. 2019;155(10):1175–1179. PMID 31314041
6. Li C, Chen J, Wang W, et al. Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e021549. PMID 30670500
7. Costa CS, Bagatin E, Martimbianco ALC, et al. Oral isotretinoin for acne. Cochrane Database of Systematic Reviews. 2018;11:CD009435. PMID 30484286

Last updated: October 10, 2026